The world is changing fast and to keep up you need local knowledge with global context.
By Felix Njini
(Bloomberg) – South Africa has for the first time contracted private companies to help with importation and distribution of Covid-19 vaccines as it seeks to step up vaccination nationwide.
The government awarded tenders to state-backed Biologicals Vaccines Institute of Southern Africa Ltd. and Imperial Logistics Ltd. to import an unspecified quantity of doses, the Department of Health said in a document on its website. DSV Healthcare Ltd. was contracted to store and distribute the doses countrywide.
On April 26, Biovac will handle delivery of South Africa’s first batch of 1 million Johnson & Johnson shots being produced locally by Aspen Pharmacare Holdings Ltd., Chief Executive Officer Morena Makhoana said by phone.
In addition, the organisation will also manage imports from Pfizer Inc., Makhoana said. The quantities that Biovac and Imperial will import will be announced by the Department of Health, he said.
The government ordered 30 million of the two-dose vaccine developed by Pfizer and BioNTech SE, which in addition to the J&J shots should be sufficient to inoculate more than two thirds of the nation’s 60 million population to achieve herd immunity.
The government, which has been slow to rollout its vaccination programme, has so far given 292,623 doses to health workers. Dispensing shots to people over 60 years and other vulnerable groups is expected to start on May 17 after delivery of the J&J vaccines on Monday, the government said.
- Engen to convert SA’s oldest oil refinery into terminal
- Naspers-owned Prosus to invest $80m in European online trader
- SA to utilise J&J vaccine after settling dispute with drugmaker
Cyril Ramaphosa: The Audio Biography
Listen to the story of Cyril Ramaphosa's rise to presidential power, narrated by our very own Alec Hogg.